Macro Man | Jan 15, 2013 03:10AM ET
Europe - Well TMM read that one wrong and regret our move against our big trend thoughts in trying to finesse the thinking that the market had got a little ahead of itself on its path back to a new normal from one of abject doom. Nevertheless, for those with ammo, adding to existing Euribor longs (or if lucky enough not to already have them, adding one) doesn't seem like a terrible idea. Either way, it appears that together with the market, we a can add someone else to the "getting a bit cocky" box. Dr. Aghi's performance was verging on the valedictory and though we detested the blinkered old bureaucracy that was the Trichet/Duisenberg ECB, the cult of personality appears to be infecting Mario. First symptom? Casting opinion on matters that aren't his to cast opinion on. Don't go all Greenspan on us now Dottore!
TMM like to think that we have seen a 3 stage capitulation on short risk positions over the last couple of weeks. First came the improving Chinese data (though many are again questioning its validity), then came the ironing out of the cliff to a hump and finally Draghi announces Europe cured (well not quite, but that appears to be the market response). With such a huge collective sigh of relief and resurgence of media coverage of upside even TMM (with their view of recovery) are wondering if in the short term things are a little ahead of themselves to the point of having bought puts in SPX on Friday looking for a turn lower in direction and higher in VIX. Much like our languishing USD/JPY puts, this is a shorter term hedge against our longer term trend expectations.
But on to more pressing things - TMM's third Non-Prediction of 2013:
3) EM equities will NOT be able to resist the improving domestic growth and inflation mix as well as the lift in the global manufacturing cycle and should handily outperform their DM counterparts.
Continuing the theme of the past few months, TMM reckon EM Equities have a lot further to go, based upon a combination of:
1. The turn in the global manufacturing cycle driven by a combination of the US consumer and pent-up CapEx-related demand from corporates.
2. Monetary and fiscal stimulus in China.
3. Reduced drag from Europe after the recent stabilisation of the PMIs (last month's dire IP numbers notwithstanding).
4. Food inflation risks overstated, particularly given upcoming reweighting in the Chinese CPI basket, meaning that the easing cycle of the past 12-18months should still be supportive of both liquidity conditions & growth.
5. A return of capital flows into EM (and Asia in particular) as real money underweights enacted in early/mid-2011 on the back of EMU-break up fears are reversed.
The below chart shows the YoY change in MSCI EM vs. DM vs. a proxy for the growth & inflation mix based upon a bunch of PMIs, export figures, money supply & inflation prints and is showing a reasonable divergence right now. TMM would argue that the divergence in 2006-8 can be explained by the BRIC-lovefest which subsequently unwound, and that of 2009 by non-linearities uncaptured by the model. The current gap looks to be around 15-17%, and as discussed above, likely a function of the very strong risk aversion of summer/autumn 2011.
Trading at just 9.6x 2013's earnings, it is amongst the cheapest of the liquid EM markets (H-Shares only beating it at 9x). In terms of price targets, TMM think the trade has about 15%-20% in it, which corresponds to the overall EM/DM mismatch in the first model chart & the underperformance vs. the S&P 500 since summer 2011:
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.